Related references
Note: Only part of the references are listed.Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells
Wei-Qing Han et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury
Amrita Dosanjh et al.
BMC GENOMICS (2013)
Expression of hypoxia-inducible factor-1 (HIF-1) in infiltrating inflammatory cells is associated with chronic allograft dysfunction and predicts long-term graft survival
Tung-Min Yu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Immunosuppressive Regimen and Interstitial Fibrosis and Tubules Atrophy at 12 Months Postrenal Transplant
Marielle A. C. J. Gelens et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Renal interstitial fibrosis: mechanisms and evaluation
Alton B. Farris et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
The Acetylase/Deacetylase Couple CREB-binding Protein/Sirtuin 1 Controls Hypoxia-inducible Factor 2 Signaling
Rui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Chronic kidney disease growth factors in renal fibrosis
Peter Boor et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Pathophysiological Consequences of HIF Activation HIF as a Modulator of Fibrosis
Volker H. Haase
HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY (2009)
Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies
Dorella Del Prete et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
The pathogenesis and treatment of chronic allograft nephropathy
Can Li et al.
NATURE REVIEWS NEPHROLOGY (2009)
Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients
Britta Höcker et al.
PEDIATRIC DRUGS (2009)
Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease
Samuel N. Heyman et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Hypoxia-inducible factor signaling in the development of tissue fibrosis
Debra F. Higgins et al.
CELL CYCLE (2008)
HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease
Shinya Mizuno et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection
Khaled Mahmoud et al.
TRANSPLANTATION (2007)
Immunohistochemical detection of hypoxia-inducible factor-1 alpha in human renal allograft biopsies
Christian Rosenberger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Hepatocyte growth factor and transforming growth factor β1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis
Anna Capuano et al.
ARTHRITIS AND RHEUMATISM (2006)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Hypoxia-inducible factors in the kidney
Volker H. Haase
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Therapeutic targets in the treatment of allograft fibrosis
RB Mannon
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure
M Franquesa et al.
GENE THERAPY (2005)
Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli
C Esposito et al.
KIDNEY INTERNATIONAL (2005)
Current understanding of HIF in renal disease
C Rosenberger et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2005)
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
YH Liu
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Hepatocyte growth factor antagonizes the profibrotic action of TGF-β1 in mesangial cells by stabilizing smad transcriptional corepressor TGIF
CS Dai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis
R Gong et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction
JW Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice
JW Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Expression of hypoxia-inducible factor-1α and -2α in hypoxic and ischemic rat kidneys
C Rosenberger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Renotropic role and therapeutic potential of HGF in the kidney
K Matsumoto et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Hepatocyte growth factor and the kidney
YH Liu
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
K Matsumoto et al.
KIDNEY INTERNATIONAL (2001)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy
S Mizuno et al.
KIDNEY INTERNATIONAL (2001)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways
YH Liu et al.
KIDNEY INTERNATIONAL (2000)
Hepatocyte growth factor in renal failure: Promise and reality
GA Vargas et al.
KIDNEY INTERNATIONAL (2000)
Hepatocyte growth factor: A regulator of extracellular matrix genes in mouse mesangial cells
NJ Laping et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
